Ingersoll Rand Inc (STU:5GD)
€ 72.24 -0.80 (-1.1%) Market Cap: 28.32 Bil Enterprise Value: 31.55 Bil PE Ratio: 34.31 PB Ratio: 3.21 GF Score: 83/100

Ingersoll Rand Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 03:30PM GMT
Release Date Price: €73.58 (-0.19%)
Ta;Von Wilson
JPMorgan - Analyst

Good morning, and it's Wednesday at the JPMorgan Healthcare Conference here in San Francisco. My name is Ta-Von Wilson, an associate and Healthcare Group based in New York. I'm pleased to host and present or introduce the Ingersoll Rand team, starting with Vicente Reynal, who is the CEO; Vik Kini, who is the CFO; and Scott Watson, SVP and General Managers of the Life Science Technologies Platform.

Vicente Reynal
Ingersoll Rand Inc - Chairman of the Board, President, Chief Executive Officer

Thank you, Ta-Von, and thank you for the invitation to this prestigious conference. We're very excited to be here with you today, the first time for us to be presenting at the conference. And so what I'm going to do is first give you a quick overview of who we are, Ingersoll Rand. And then we're going to kind of double-click into our Life Science platform and Scott Watson is going to provide you with that presentation.

Forward-looking statements, please read them at your pleasure and your time. So feel free to ask

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot